Company / Capital Expenditures
Nutex Health, Inc. Capital Expenditures History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$2.5M
FY2025
5-year range
$2.3M / $36.9M
FY2021-FY2025
Trend
+9.6%
vs FY2024
Sector context
#316 of 325
Industrials
What the data says
Among 325 Industrials companies, Nutex Health, Inc. is in the bottom 3% for capital expenditures. Capital Expenditures returned to growth in FY2025 after 4 years of decline, reaching $3M.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -47.1%.
Declined from $9M to $3M over the past 2 years.
Industrials sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -44.3%
- 5-Year CAGR
- -47.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in IndustrialsTop 97% of 325This company $2.5M Sector average $298.1M
▼
-99.2% below sector average
Key checks
Key Insights
- 5-year CAGR of -47.1%, indicating a declining trend.
- In FY2025, capital expenditures increased 9.6% year-over-year.
- Ranks #316 out of 325 companies in the Industrials sector.
- Peak capital expenditures was recorded in FY2020.
Company context
Key Data Points
- Strong profit margin: 40.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5M | +9.6% |
| FY2024 | $2.3M | -75.7% |
| FY2023 | $9.5M | -35.1% |
| FY2022 | $14.6M | -60.4% |
| FY2021 | $36.9M | -39.7% |
| FY2020 | $61.2M | +72742.0% |
| FY2019 | $84.0K | - |
| FY2018 | $0 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026